Association of IL1A and IL1B loci with primary open angle glaucoma

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Mookherjee, Suddhasil ^a   Banerjee, Deblina ^a   Chakraborty, Subhadip ^a   Banerjee, Antara ^a   Mukhopadhyay, Indranil ^b   Sen, Abhijit ^c   Ray, Kunal ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

^c Dristi Pradip   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1A; INTERLEUKIN 1B; UNCLASSIFIED DRUG; IL1A PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CONTROLLED STUDY; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GROUPS BY AGE; HAPLOTYPE; HUMAN; INDIAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INDIA; MIDDLE AGED; MULTIGENE FAMILY;

ALLELES; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA, OPEN-ANGLE; HAPLOTYPES; HUMANS; INDIA; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTRAOCULAR PRESSURE; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77953648392     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-99     Document Type: Article

References (42)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006, 90(3):262-267. 1856963, 16488940.
2. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, et al. Identification of a gene that causes primary open angle glaucoma. Science (New York, NY) 1997, 275(5300):668-670.
3. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, Ritch R, Kreutzer D, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295(5557):1077-1079.
4. Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E, Liebmann J, Ritch R, Heon E, Crick RP, Child A, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005, 14(6):725-733.
5. Gong G, Kosoko-Lasaki S, Haynatzki G, Lynch HT, Lynch JA, Wilson MR. Inherited, familial and sporadic primary open-angle glaucoma. J Natl Med Assoc 2007, 99(5):559-563. 2576058, 17534014.
6. Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med 2001, 7(3):304-309. 1945815, 11231628.
7. Halpern DL, Grosskreutz CL. Glaucomatous optic neuropathy: mechanisms of disease. Ophthalmol Clin North Am 2002, 15(1):61-68.
8. Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol 2004, 15(2):80-84.
9. Tezel G, Yang J, Wax MB. Heat shock proteins, immunity and glaucoma. Brain Res Bull 2004, 62(6):473-480.
10. Ikeda Y, Maruyama I, Nakazawa M, Ohguro H. Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmol 2002, 46(1):13-17.
11. Tezel G, Seigel GM, Wax MB. Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 1998, 39(12):2277-2287.
12. Latalska M, Gerkowicz M, Kosior-Jarecka E, Koziol-Montewka M, Pietras-Trzpiel M. [Serum and aqueous humor antibodies to beta-2 glycoprotein I in patients with glaucoma and cataract]. Klin Oczna 2004, 106(1-2 Suppl):162-163.
13. Shaftel SS, Griffin WS, O'Banion MK. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 2008, 5:7. 2335091, 18302763.
14. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 2007, 104(33):13444-13449. 1940230, 17684098.
15. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. European neurology 2002, 47(3):165-168.
16. Tamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K, Izumi Y, Matsumoto M, Mishima HK. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006, 246(1-2):79-83.
17. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. The New England journal of medicine 1986, 315(8):485-487.
18. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004, 363(9422):1711-1720.
19. Ressiniotis T, Griffiths PG, Birch M, Keers S, Chinnery PF. The role of apolipoprotein E gene polymorphisms in primary open-angle glaucoma. Archives of ophthalmology 2004, 122(2):258-261.
20. Vickers JC, Craig JE, Stankovich J, McCormack GH, West AK, Dickinson JL, McCartney PJ, Coote MA, Healey DL, Mackey DA. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis 2002, 8:389-393.
21. Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmuller F, Muller U, Kurz A, Zimmer R, Evans RM, et al. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 2000, 55(4):480-483.
22. Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 2000, 47(3):365-368.
23. How AC, Aung T, Chew X, Yong VH, Lim MC, Lee KY, Toh JY, Li Y, Liu J, Vithana EN. Lack of association between interleukin-1 gene cluster polymorphisms and glaucoma in Chinese subjects. Invest Ophthalmol Vis Sci 2007, 48(5):2123-2126.
24. Lin HJ, Tsai SC, Tsai FJ, Chen WC, Tsai JJ, Hsu CD. Association of interleukin 1beta and receptor antagonist gene polymorphisms with primary open-angle glaucoma. Ophthalmologica 2003, 217(5):358-364.
25. Wang CY, Shen YC, Lo FY, Su CH, Lee SH, Lin KH, Tsai HY, Kuo NW, Fan SS. Polymorphism in the IL-1alpha (-889) locus associated with elevated risk of primary open angle glaucoma. Mol Vis 2006, 12:1380-1385.
26. Wang CY, Shen YC, Lo FY, Su CH, Lee SH, Tsai HY, Fan SS. Normal tension glaucoma is not associated with the interleukin -1alpha (-889) genetic polymorphism. J Glaucoma 2007, 16(2):230-233.
27. Wang CY, Shen YC, Su CH, Lo FY, Lee SH, Tsai HY, Fan SS. Investigation of the association between interleukin-1beta polymorphism and normal tension glaucoma. Mol Vis 2007, 13:719-723. 2765469, 17563722.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 2005, 21(2):263-265.
29. Acharya M, Mookherjee S, Bhattacharjee A, Bandyopadhyay AK, Daulat Thakur SK, Bhaduri G, Sen A, Ray K. Primary role of CYP1B1 in Indian juvenile-onset POAG patients. Mol Vis 2006, 12:399-404.
30. Acharya M, Mookherjee S, Bhattacharjee A, Thakur SK, Bandyopadhyay AK, Sen A, Chakrabarti S, Ray K. Evaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent change. BMC Mol Biol 2007, 8(1):21. 1838427, 17359525.
31. Bhattacharjee A, Banerjee D, Mookherjee S, Acharya M, Banerjee A, Ray A, Sen A, Ray K. Variation Consortium TI Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma. Mol Vis 2008, 14:841-850. 2375325, 18483560, Variation Consortium TI.
32. Lin HJ, Tsai FJ, Hung P, Chen WC, Chen HY, Fan SS, Tsai SW. Association of E-cadherin gene 3'-UTR C/T polymorphism with primary open angle glaucoma. Ophthalmic research 2006, 38(1):44-48.
33. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997, 388(6645):878-881.
34. Chintala SK, Zhang X, Austin JS, Fini ME. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. The Journal of biological chemistry 2002, 277(49):47461-47468.
35. Zhang X, Chintala SK. Influence of interleukin-1 beta induction and mitogen-activated protein kinase phosphorylation on optic nerve ligation-induced matrix metalloproteinase-9 activation in the retina. Experimental eye research 2004, 78(4):849-860.
36. Levin LA. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy. Survey of ophthalmology 1999, 43(Suppl 1):S98-101.
37. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(17):9944-9948. 22315, 10449799.
38. Genetic landscape of the people of India: a canvas for disease gene exploration. Journal of genetics 2008, 87(1):3-20.
39. Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi LM, Biunno I. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics 2002, 54(2):82-86.
40. Hulkkonen J, Laippala P, Hurme M. A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals. Eur Cytokine Netw 2000, 11(2):251-255.
41. Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW, Breedveld FC, Seymour AB. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis and rheumatism 2004, 50(6):1976-1983.
42. Stoilova D, Child A, Trifan OC, Crick RP, Coakes RL, Sarfarazi M. Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2cen-q13 region. Genomics 1996, 36(1):142-150.